Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Abel A. Pavía-López
147  Ergebnisse:
englisch X
Personensuche X
?
1

Risk stratification and lipid evaluation in mexican patient..:

De los Ríos-Ibarra, Manuel Odín ; Leiva-Pons, José Luis ; Rodríguez-Reyes, Humberto...
Atherosclerosis Plus.  50 (2022)  - p. 32-39 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Safety and tolerability of β-blockers: importance of cardio..:

Marti, Hans-Peter ; Pavía López, Abel Alberto ; Schwartzmann, Pedro
Current Medical Research and Opinion.  40 (2024)  sup1 - p. 55-62 , 2024
Link: https://doi.org/10.1080/..
 
?
3

Real-World Insights into Evolocumab Use in Patients with Hy..:

Gupta, Milan ; Wani, Rajvi J. ; Al Faraidy, Khalid...
Cardiology and Therapy.  12 (2023)  4 - p. 703-722 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Guía de práctica clínica mexicana para el diagnóstico y tra..:

Abel A. Pavía-López ; Marco A. Alcocer-Gamba ; Edith D. Ruiz-Gastélum...
https://www.archivoscardiologia.com/frame_esp.php?id=468.  , 2022
Link: https://doi.org/10.24875..
 
?
5

Risk stratification and lipid evaluation in mexican patient..:

De los Ríos-Ibarra, Manuel Odín ; Leiva-Pons, José Luis ; Rodríguez-Reyes, Humberto...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833238/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Guía de práctica clínica mexicana para el diagnóstico y tra..:

Pavía-López, Abel A ; Alcocer-Gamba, Marco A ; Ruiz-Gastelum, Edith D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290432/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
7

Risk stratification and lipid evaluation in mexican patient..:

Manuel Odín De los Ríos-Ibarra ; José Luis Leiva-Pons ; Humberto Rodríguez-Reyes...
http://www.sciencedirect.com/science/article/pii/S2667089522000463.  , 2022
Link: https://doi.org/10.1016/..
 
?
8

Real-World Insights into Evolocumab Use in Patients with Hy..:

Milan Gupta ; Rajvi J. Wani ; Khalid Al Faraidy...
https://doi.org/10.1007/s40119-023-00334-5.  , 2023
Link: https://doi.org/10.1007/..
 
?
9

Clinical Risk Score to Predict Pathogenic Genotypes in Pati..:

Escobar-Lopez, Luis ; Ochoa, Juan Pablo ; Royuela, Ana...
http://hdl.handle.net/10668/22282.  , 2022
Link: http://hdl.handle.net/10..
 
?
10

Clinical Risk Score to Predict Pathogenic Genotypes in Pati..:

Escobar-Lopez, Luis ; Ochoa, Juan Pablo ; Royuela, Ana...
10.1016/j.jacc.2022.06.040.  , 2022
Link: https://hdl.handle.net/2..
 
?
11

Clinical Risk Score to Predict Pathogenic Genotypes in Pati..:

Escobar-Lopez, Luis ; Ochoa, Juan Pablo ; Royuela, Ana...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10804447/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
12

Clinical Risk Score to Predict Pathogenic Genotypes in Pati..:

Escobar-Lopez L ; Ochoa J. P ; Royuela A...
info:eu-repo/semantics/altIdentifier/pmid/36109106.  , 2022
Link: http://hdl.handle.net/11..
 
?
13

Outcomes and effect of somatic mutations after erythropoies..:

Caballero, Juan Carlos ; Dávila, Julio ; López-Pavía, María...
Therapeutic Advances in Hematology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.1177/..
 
?
14

Treatment patterns and outcomes of 2310 patients with secon..:

Martínez-Cuadrón, David ; Megías-Vericat, Juan E. ; Serrano, Josefina...
Blood Advances.  6 (2022)  4 - p. 1278-1295 , 2022
Link: https://doi.org/10.1182/..
 
?
15

Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute M..:

Labrador, Jorge ; Martínez-Cuadrón, David ; de la Fuente, Adolfo...
Cancers.  14 (2022)  9 - p. 2342 , 2022
Link: https://doi.org/10.3390/..
 
1-15